CASI Pharmaceuticals, Inc.
Price Action
Technical Summary
DOWNTRENDCASI Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 1), showing significant lag compared to the market leaders. Earnings contraction of 24% provides fundamental context to the price action. However, RSI is deeply oversold at 24, suggesting potential for a mean-reversion bounce.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.41 | -62.99% | BELOW |
| 50 SMA | $0.73 | -79.48% | BELOW |
| 100 SMA | $0.95 | -84.08% | BELOW |
| 150 SMA | $1.29 | -88.37% | BELOW |
| 200 SMA | $1.35 | -88.85% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CASI in an uptrend right now?
CASI has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is CASI overbought or oversold?
CASI's RSI (14) is 24. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.
Is CASI outperforming the market?
CASI has a Relative Strength (RS) Rating of 1 out of 99. CASI is currently lagging the broader market.
Where is CASI in its 52-week range?
CASI is trading at $0.15, which is 5% of its 52-week high ($3.09) and 3% above its 52-week low ($0.05).
How volatile is CASI?
CASI has a Beta of -0.12 and 52-week volatility of 154%. It's less volatile than the S&P 500 - generally more stable.